Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

about

Neutrophil activation during attacks in patients with hereditary angioedema due to C1-inhibitor deficiency Angioedema Phenotypes: Disease Expression and Classification."Nuts and Bolts" of Laboratory Evaluation of Angioedema.

P2860

Q36361422-D8A4F394-A48C-4908-BB87-1EF6D888C5C9 Q38817627-D52489E4-F95A-4638-95E5-67A6F865517B Q38824626-B7C682D4-03F5-40C8-966D-909215597255

P2860

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

Item

http://www.wikidata.org/entity/Q36901050

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

@en

type

Item

label

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

@en

prefLabel

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

@en

P1476

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening

@en

P2093

Alberto López-Lera

http://www.w3.org/2001/XMLSchema#string

Fátima Sánchez Cabo

http://www.w3.org/2001/XMLSchema#string

Sofía Garrido

http://www.w3.org/2001/XMLSchema#string

P2860

Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III

Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease

Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis

Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses

A comparison of normalization methods for high density oligonucleotide array data based on variance and bias

Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases.

Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities.

A variant in XPNPEP2 is associated with angioedema induced by angiotensin I-converting enzyme inhibitors

Cross-talk between the complement and the kinin system in vascular permeability.

Induction of innate immune responses by SIV in vivo and in vitro: differential expression and function of RIG-I and MDA5.

P2888

1750-1172-8-77

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1750-1172-8-77

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ana Dopazo

M López-Trascasa

P577

2013-05-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236922674

http://www.w3.org/2001/XMLSchema#string

P6179

1011138597

http://www.w3.org/2001/XMLSchema#string

P698

23688356

http://www.w3.org/2001/XMLSchema#string

P932

3671971

http://www.w3.org/2001/XMLSchema#string

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

about

P2860

P2860

Disease-modifying factors in hereditary angioedema: an RNA expression-based screening.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P478

P50

P577

P5875

P6179

P698

P932